DE2445801C2 - Parenteral oder oral verabreichbares Arzneimittel zur Behandlung von diabetischer Ketoacidose - Google Patents

Parenteral oder oral verabreichbares Arzneimittel zur Behandlung von diabetischer Ketoacidose

Info

Publication number
DE2445801C2
DE2445801C2 DE2445801A DE2445801A DE2445801C2 DE 2445801 C2 DE2445801 C2 DE 2445801C2 DE 2445801 A DE2445801 A DE 2445801A DE 2445801 A DE2445801 A DE 2445801A DE 2445801 C2 DE2445801 C2 DE 2445801C2
Authority
DE
Germany
Prior art keywords
treatment
parenterally
medicinal product
orally administrable
diabetic ketoacidosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2445801A
Other languages
German (de)
English (en)
Other versions
DE2445801A1 (de
Inventor
Yuzo Naruto Tokushima Kawashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE2445801A1 publication Critical patent/DE2445801A1/de
Application granted granted Critical
Publication of DE2445801C2 publication Critical patent/DE2445801C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE2445801A 1973-09-26 1974-09-25 Parenteral oder oral verabreichbares Arzneimittel zur Behandlung von diabetischer Ketoacidose Expired DE2445801C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP48107613A JPS5058213A (ja) 1973-09-26 1973-09-26

Publications (2)

Publication Number Publication Date
DE2445801A1 DE2445801A1 (de) 1975-04-03
DE2445801C2 true DE2445801C2 (de) 1985-05-09

Family

ID=14463599

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2445801A Expired DE2445801C2 (de) 1973-09-26 1974-09-25 Parenteral oder oral verabreichbares Arzneimittel zur Behandlung von diabetischer Ketoacidose

Country Status (5)

Country Link
US (1) US3929995A (ja)
JP (1) JPS5058213A (ja)
DE (1) DE2445801C2 (ja)
FR (1) FR2244487B1 (ja)
GB (1) GB1474424A (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1143611B (it) * 1977-11-03 1986-10-22 Sigma Tau Ind Farmaceuti Applicazione della acetil-carnitina nella terapia delle affezioni cardiache di/tipo anossico,ischemico,cardiotossico e nelle sindromi aritmiche
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1133010B (it) * 1980-05-15 1986-07-09 Sigma Tau Ind Farmaceuti Metodo terapuetico per il trattamento del diabete mellito a insorgenza giovanile e composizione farmaceutica per tale metodo
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
US4731360A (en) * 1985-08-16 1988-03-15 Merck & Co., Inc. Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments
IT1231944B (it) * 1989-05-05 1992-01-16 Sigma Tau Ind Farmaceuti Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina
US10799564B1 (en) 2019-05-06 2020-10-13 Baxter International Inc. Insulin premix formulation and product, methods of preparing same, and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624887A (en) * 1970-03-02 1971-12-07 Bunker Ramo Pin and socket removal tool

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Biochemistry 58, 1967, S. 796-797 *
Physiologische Chemie, Berlin 1954, Bd. 2, T. 1a, S. 769 *

Also Published As

Publication number Publication date
FR2244487A1 (ja) 1975-04-18
AU7226574A (en) 1975-05-01
DE2445801A1 (de) 1975-04-03
FR2244487B1 (ja) 1978-06-30
GB1474424A (en) 1977-05-25
JPS5058213A (ja) 1975-05-21
US3929995A (en) 1975-12-30

Similar Documents

Publication Publication Date Title
US4416886A (en) Method of treating pruritis and composition therefor
DE69930243T2 (de) Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazu
DE2445801C2 (de) Parenteral oder oral verabreichbares Arzneimittel zur Behandlung von diabetischer Ketoacidose
DE3338995A1 (de) Bilobalid enthaltende arzneimittel
DE3137125C2 (ja)
EP1782824B1 (de) Pharmazeutische Zubereitungen als Hydrogel, die Diaminooxidase enthalten
Kandrotas et al. Ketoconazole effects on methylprednisolone disposition and their joint suppression of endogenous cortisol
DE3742127C2 (de) Pharmazeutische Präparate
Moe et al. Toxicology of hydroxypyridinethione
DE2716402A1 (de) 7-(2,3-dihydroxypropyl)-1,3-di-n- propylxanthin, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel
DE2530862C2 (de) Verwendung von Uridin-5'-diphosphat zur Verhütung und Behandlung von Alkoholismus
EP3135273A1 (de) Mineralstoffzusammensetzungen zur anregung des kohlenhydratstoffwechsels
DE2726392A1 (de) Mittel zur bekaempfung der venoesen thrombose
DE60203844T2 (de) Verwendung von Hydantoin und seinen Derivaten gegen Hypalbuminämie
DE2416216C2 (de) Oral verabreichbares pharmazeutisches Gemisch
CA2055661A1 (en) Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
DE2731736A1 (de) 5-m-tolyloxyuracil, verfahren zu dessen herstellung und dessen verwendung als arzneimittel zur behandlung von magengeschwueren
DE1900772C3 (de) Salz aus N,N-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel
DE3141970C2 (ja)
Motew et al. Evidence that adenosine contributes to maintenance of hepatosplanchnic blood flow during peritoneal sepsis in rats
JPH07506568A (ja) 糖尿病治療のための既存の薬剤の使用
DE2157201C3 (de) Verbesserte feste orale Applikationsform von Raubasin
DE2728589A1 (de) Verwendung von 2-(2,2-disubstituierten)-aethylimidazolinen bei der bekaempfung von diabetes
DE1809119B2 (de) Infarktprophylaktikum
DE2049115C3 (de) Verwendung von Calcium-5-butylpicolinat und/oder Calcium-5-pentylpicolinat bei der Bekämpfung des Parkinsonismus mit 3-(3,4-Dihydroxyphenyl)-L-alanin (L-Dopa)

Legal Events

Date Code Title Description
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee